- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02048501
Changes in Gut Hormones, Body Composition and Energy Expenditure After Roux-en-Y
Gut Hormone, Energy Expenditure and Body Composition Change in Subjects Who Succeed or Fail to Sustain Weight Loss After Roux-en-Y Gastric Bypass
The purpose of this study is to gain a better understanding of the mechanism of weight regain through gut hormone (substances in the gut that control various functions of the digestive organs) and energy expenditure (the amount of energy a person uses to complete bodily activities).
Our hypothesis is that gut hormone response might be different among subjects who are able to maintain weight loss and subjects with weight regain.
For this study, investigators will measure fasting and postprandial (happening after a meal) gut hormones, bile acid, amino acids, vitamin B, vitamin D, myokines and adipokine levels in obese individuals who are at least 2 years after a Roux-en-Y gastric bypass (RYGB). Investigators will also measure resting metabolic rate (RMR) (the amount of energy expended daily) and body composition (the proportion of fat, muscle, and bone of an individual's body). The subjects body composition will be analyzed, including fat mass and fat free mass, by a Dual-Energy X-ray Absorptiometry (DEXA). This study will provide more information regarding the effect of RYGB on gut hormones, adipokines, bile acids, amino acids, and energy expenditure and body compositions.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27704
- Duke Center for Metabolic and Weight Loss Surgery
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 18-65 years of age
- Ability and willingness to provide informed consent
Exclusion Criteria:
- Surgical/anatomical failure such as pouch enlargement, anastomosis dilation, formation of a gastrogastric fistula,
- Currently on medication that might affect weight gain including GLP-1 analog
- Inability to provide informed written consent.
- Any known history of abnormal thyroid function.
- Females who are pregnant.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Weight Regain
The weight regain group will include 20 subjects who underwent Roux-en-Y gastric bypass (RYGB) with a follow up of at least 2 years and have experienced excess weight loss (EWL) of at least 50% at 12 (+ 2) months post-operatively and regained at least 15% of the post-operative nadir weight.
|
Each subject will have their resting metabolic rate (RMR) measured.
The RMR is assessed by indirect calorimetry measured with the metabolic cart.
Oxygen consumption is converted into kilocalories.
Subjects will be advised to avoid strenuous exercise for at least 48 hours prior to participation in the study and to sleep at least 6-8 hours the night before.
Smoking and consuming caffeine will be prohibited 12 hours before the study begins.
During a separate appointment on the same day, or within 7 business days if same day is not possible, a body compositions analysis, including fat mass and fat free mass, will be assessed by dual-energy x-ray absorptiometry (DEXA), using a Hologic system.
Other Names:
Subjects will be asked to complete a 100-mm Visual Analog scale (VAS) to assess their appetite.
The VAS will be completed prior to the meal stimulation test and at 30-minutes, 1-hour, 90 minutes and 2-hours after the meal.
The VAS will contain questions assessing food intake, appetite, and hunger.
Subjects will consume a mixed-nutrient liquid meal 240-ml in 20 minutes.
Prior to the meal stimulation test, a baseline 10-ml blood sample will be collected.
The, during the meal stimulation test, 10-ml venous blood sample will be collected at 30 minute intervals up to two hours, for a total of 5 samples including the baseline sample.
The blood samples will be used to measure fasting blood glucose, adipokines, myokines, gut hormones, amino acids, bile acids, vitamin B and vitamin D analysis with the appropriate assay method.
|
|
Other: Sustained Weight Loss (SWL)
The sustained weight loss group will include 20 subjects who underwent Roux-en-Y gastric bypass (RYGB) with a follow up of at least 2 years and have experienced excess weight loss (EWL) of at least 50% at 12 (+ 2) months post-operatively and have regained less than 15% of the post-operative nadir weight.
|
Each subject will have their resting metabolic rate (RMR) measured.
The RMR is assessed by indirect calorimetry measured with the metabolic cart.
Oxygen consumption is converted into kilocalories.
Subjects will be advised to avoid strenuous exercise for at least 48 hours prior to participation in the study and to sleep at least 6-8 hours the night before.
Smoking and consuming caffeine will be prohibited 12 hours before the study begins.
During a separate appointment on the same day, or within 7 business days if same day is not possible, a body compositions analysis, including fat mass and fat free mass, will be assessed by dual-energy x-ray absorptiometry (DEXA), using a Hologic system.
Other Names:
Subjects will be asked to complete a 100-mm Visual Analog scale (VAS) to assess their appetite.
The VAS will be completed prior to the meal stimulation test and at 30-minutes, 1-hour, 90 minutes and 2-hours after the meal.
The VAS will contain questions assessing food intake, appetite, and hunger.
Subjects will consume a mixed-nutrient liquid meal 240-ml in 20 minutes.
Prior to the meal stimulation test, a baseline 10-ml blood sample will be collected.
The, during the meal stimulation test, 10-ml venous blood sample will be collected at 30 minute intervals up to two hours, for a total of 5 samples including the baseline sample.
The blood samples will be used to measure fasting blood glucose, adipokines, myokines, gut hormones, amino acids, bile acids, vitamin B and vitamin D analysis with the appropriate assay method.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in pre and post-prandial plasma Glucagon-like peptide-1 (GLP-1)
Time Frame: Prior to meal stimulation test, 30 minutes, 60 minutes, 90 minutes and 120 after the meal stimulation test.
|
The primary endpoints are a difference in pre postprandial plasma GLP-1 and PYY in subjects who underwent RYGB who succeed or fail to lose and maintain EWL goal.
|
Prior to meal stimulation test, 30 minutes, 60 minutes, 90 minutes and 120 after the meal stimulation test.
|
|
Difference in pre and post-prandial Peptide YY (PYY)
Time Frame: Priot to the meal stimulation test, 30 minutes,60 minutes, 90 minutes, and 120 minutes after the meal stimulation test.
|
The primary endpoints are a difference in pre postprandial plasma GLP-1 and PYY in subjects who underwent RYGB who succeed or fail to lose and maintain EWL goal.
|
Priot to the meal stimulation test, 30 minutes,60 minutes, 90 minutes, and 120 minutes after the meal stimulation test.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Chan Park, MD, Duke University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00049254
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Resting Metabolic Rate (RMR)
-
Temple UniversityUniversity of Pennsylvania; St. Luke's-Roosevelt Hospital CenterCompletedModerate Behavior Management | Intensive Behavior ManagementUnited States
-
University of AberdeenEnrolling by invitationHuntington DiseaseUnited Kingdom
-
Milton S. Hershey Medical CenterCompletedDietary Habits | Spinal Cord InjuriesUnited States
-
University of Sao Paulo General HospitalCompleted
-
Pennington Biomedical Research CenterCompleted
-
Karolinska InstitutetThe Swedish Research Council; Swedish Heart Lung FoundationCompleted
-
Gemin XCompletedMyelodysplastic SyndromesCanada, United States
-
Gemin XCompletedHodgkin's LymphomaUnited States
-
Hacettepe UniversityAnkara Bilkent City HospitalRecruitingInflammation | Colorectal Cancer | Diet, Healthy | Diet Habit | Nutrition Aspect of CancerTurkey
-
Lindenwood UniversityCompletedMetabolic Syndrome | CaffeineUnited States